UNIVERSITY OF COPENHAGEN Project title Novel Treatments of Neuromuscular Disease Mentor 1 Pontus Gourdon, MSc & PhD,
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
dkbio17 hashtag on Twitter
NMD Pharma
NMD Pharma A/S - Aarhus N - 'Regnskaber, roller og: 2020 in Anders Nykjær's group. Email: nille_bt, pbt, pbt. New Affiliation: NMD Pharma at INCUBA Skejby
In Boston, Danish Life Science Companies and US Investors Line Up for DKBIO2018 | by Denmark in New York | Medium
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670 - Opera News
Big deal: NMD flexes series A muscles - University Venturing: News, Data, and Events - Global University Venturing
Thomas H. Pedersen - CEO at NMD Pharma | The Org
NMD Pharma
Thomas K. Petersen - COO at NMD Pharma | The Org
NMD Pharma
NMD Pharma | The Lundbeck Foundation
NMD Pharma A/S | LinkedIn
NMD Pharma Receives... - Unite - Myasthenia Gravis Community | Facebook
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma begins first clinical trial: "Our entire team can be enormously proud"
NMD Pharma
NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma company information, funding & investors | Dealroom.co
Biotek-kometen NMD Pharma fortsætter vækstrejse i Aarhus
NMD Pharma A/S | LinkedIn
NMD Pharma - PIR International
